Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of Irbesartan and Amlodipine
combined therapy in patients with essential hypertension inadequately controlled on
Irbesartan monotherapy